Zydus Lifesciences Limited (NSE:ZYDUSLIFE)
906.90
-14.80 (-1.61%)
At close: Mar 2, 2026
Zydus Lifesciences Employees
Zydus Lifesciences had 27,917 employees as of March 31, 2025. The number of employees increased by 996 or 3.70% compared to the previous year.
Employees
27,917
Change (1Y)
996
Growth (1Y)
3.70%
Revenue / Employee
9.35M INR
Profits / Employee
1.77M INR
Market Cap
912.55B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 27,917 | 996 | 3.70% |
| Mar 31, 2024 | 26,921 | 3,895 | 16.92% |
| Mar 31, 2023 | 23,026 | -717 | -3.02% |
| Dec 31, 2022 | 23,000 | -743 | -3.13% |
| Sep 30, 2022 | 23,000 | - | - |
| Jun 30, 2022 | 23,000 | -1,412 | -5.78% |
| Mar 31, 2022 | 23,743 | -669 | -2.74% |
| Mar 31, 2021 | 24,412 | -588 | -2.35% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Cipla | 30,313 |
| Aurobindo Pharma | 27,707 |
| Mankind Pharma | 19,620 |
| Alkem Laboratories | 18,785 |
| Ipca Laboratories | 16,778 |
| Glenmark Pharmaceuticals | 15,800 |
| Divi's Laboratories | 10,542 |
| Ajanta Pharma | 9,628 |
Zydus Lifesciences News
- 17 hours ago - Top stocks for trade today, March 2: Tata Motors, Hero MotoCorp, Zydus Lifesciences, Aurobindo Pharma, Vedanta and more - Business Upturn
- 2 days ago - Zydus Lifesciences secures USFDA final approvals for Ivermectin Tablets USP, 3 mg and Dapsone Tablets USP, 25 mg and 100 mg - Business Upturn
- 4 days ago - Zydus to launch semaglutide injection in India - The Times of India
- 4 days ago - Top stocks to watch today, Feb 26: NALCO, Hindustan Zinc, Zydus Lifesciences, Tata Power, Waaree Energies and more - Business Upturn
- 5 days ago - Zydus Lifesciences to launch Semaglutide Injection in India - Business Upturn
- 11 days ago - Zydus Lifesciences lunches Anyra, India’s first indigenously developed Aflibercept 2 mg biosimilar for retinal diseases - Business Upturn
- 13 days ago - Zydus Lifesciences launches India’s first affordable OPEP device PEPAIR - Business Upturn
- 17 days ago - Zydus Lifesciences Ltd (BOM:532321) Q3 2026 Earnings Call Highlights: Strong Revenue Growth ... - GuruFocus